Higashiyama, Ryoko Inaba
Horinouchi, Hidehito http://orcid.org/0000-0001-9090-801X
Kuchiba, Aya
Matsumoto, Yuji
Murakami, Shuji
Goto, Yasushi
Kanda, Shintaro
Fujiwara, Yutaka
Yamamoto, Noboru
Ohe, Yuichiro
Article History
Received: 27 June 2022
Accepted: 9 July 2022
First Online: 28 July 2022
Declarations
:
: Dr. Higashiyama has nothing to disclose. Dr. Horinouchi reports grants and personal fees from BMS, grants and personal fees from MSD, grants and personal fees from Chugai, grants and personal fees from Roche, grants and personal fees from Novartis, grants and personal fees from Astra Zeneca, grants from Abbvie, grants from Merck Biophama, grants from Daiichi-Sankyo, grants from Janssen grants from Genomic Health, personal fees from Lilly, personal fees from Kyowa-Kirin, grants and personal fees from Ono, outside the submitted work. Dr. Kuchiba has nothing to disclose. Dr. Matsumoto reports grants from National Cancer Center Research and Development Fund, grants from Grant-in-Aid for Scientific Research on Innovative Areas, grants from Hitachi, Ltd., personal fees from Olympus, personal fees from AstraZeneca, personal fees. from Novartis, personal fees from COOK, personal fees from AMCO INC, personal fees from Thermo Fisher Scientific, personal fees from Erbe Elektromedizin GmbH, personal fees from Fujifilm, personal fees from Chugai, personal fees from Eli Lilly, outside the submitted work. Dr. Murakami reports personal fees from AstraZeneca, personal fees from MSD, personal fees from ONO Pharmaceutical, personal fees from Eli Lilly, personal fees from Chugai Pharmaceutical, personal fees from Novartis, personal fees from MERCK, outside the submitted work. Dr. Goto reports grants and personal fees from Eli Lilly, personal fees from Chugai, grants and personal fees from Taiho Pharmaceutical, personal fees from Boehringer Ingelheim, grants and personal fees from Pfizer, grants and personal fees from Novartis, grants and personal fees from AstraZeneca, personal fees from MSD, personal fees from Guardant Health, grants and personal fees from Ono Pharmaceutical, grants from Kyorin, grants and personal fees from Daiichi Sankyo, personal fees from Illumina, grants and personal fees from Bristol Myers Squibb, grants from Preferred Network, grants from Abbvie, personal fees from Merck, personal fees from Thermo Fischer, outside the submitted work. Dr. Kanda has nothing to disclose. Dr. Fujiwara reports personal fees from Astra Zeneca, personal fees from Daiichi Sankyo, personal fees from ONO Pharmaceutical, personal fees from Otsuka Pharmaceutical, grants and personal fees from Chugai Pharmaceutical, personal fees from Novartis, personal fees from Yakult, grants and personal fees from Bristol-Myers Squibb, personal fees from Pfizer, personal fees from Takeda, grants from AnHeart Therapeutics, grants and personal fees from Eli Lilly, personal fees from Chiome Bioscience, grants from Amgen, outside the submitted work.
: The study was approved by the Institutional Review Board of the National Cancer Center Hospital (No. 2015–355).
: Informed consent was obtained from all individual participants included in the study.
: Not required.